JW Life Science Corp
KRX:234080
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
JW Life Science Corp
KRX:234080
|
KR |
|
T
|
Thonburi Medical Centre PCL
SET:KDH
|
TH |
|
Vigil Neuroscience Inc
NASDAQ:VIGL
|
US |
|
S
|
SA San Miguel AGICI y F
BCBA:SAMI
|
AR |
|
G
|
Goodman Property Trust
NZX:GMT
|
NZ |
|
R
|
Rex Trueform Group Ltd
JSE:RTN
|
ZA |
|
Liquidmetal Technologies Inc
OTC:LQMT
|
US |
|
Hycroft Mining Holding Corporation
NASDAQ:HYMC
|
US |
|
Karsu Tekstil Sanayi ve Ticaret AS
IST:KRTEK.E
|
TR |
|
Atlas Critical Minerals Corp
NASDAQ:ATCX
|
BR |
Wall Street
Price Targets
Price Targets Summary
JW Life Science Corp
According to Wall Street analysts, the average 1-year price target for
JW Life Science Corp
is 18 360 KRW
with a low forecast of 18 180 KRW and a high forecast of 18 900 KRW.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is JW Life Science Corp's stock price target?
Price Target
18 360
KRW
According to Wall Street analysts, the average 1-year price target for
JW Life Science Corp
is 18 360 KRW
with a low forecast of 18 180 KRW and a high forecast of 18 900 KRW.
What is JW Life Science Corp's Revenue forecast?
Projected CAGR
11%
For the last 9 years the
compound annual growth rate for
JW Life Science Corp's revenue is
7%.
The projected
CAGR
for the next 3 years is
11%.
What is JW Life Science Corp's Operating Income forecast?
Projected CAGR
2%
For the last 9 years the
compound annual growth rate for
JW Life Science Corp's operating income is
8%.
The projected
CAGR
for the next 3 years is
2%.
What is JW Life Science Corp's Net Income forecast?
Projected CAGR
-11%
For the last 9 years the
compound annual growth rate for
JW Life Science Corp's net income is
15%.
The projected
CAGR
for the next 3 years is
-11%.
